Abbvie Inc (ABBV) Stock Price, Quote & News

Company Profile

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 847 932 7900

Website: www.abbvie.com

Address:

1 North Waukegan Road, North Chicago, United States

UsingAGodAlgorithm May. 1 at 10:08 PM

$SE (-75% from short entry) We are the best on ST as far as we have seen. Check our profile We also covered these names. $ABBV $PLTR $MU $MA

0 · Reply

SlightlyHippy May. 1 at 9:31 PM

$JNJ & $ABBV pick up the dips!!

0 · Reply

55X_ROI_Q1_2026 May. 1 at 6:34 PM

$ABBV @IrishFlyGirlQueenforever congratulations to you on the rest of your life! - Guess you won't be heading to the SLS Careers Link, not that SLS is HIRING ANY ONE -- NO OPEN VACANCIES ... - Managerial MALPRACTICE to NOT BE HIRING with 2 Commercially Viable Assets. no hiring is a screaming tell, the term sheets, have been back and forth a few times. - Wishing you all your dreams come true. "Forever is our today ... who wants to Live FOREVER" 47th Like of this post --- $MRK - $ABBV

0 · Reply

Chartist0_0 May. 1 at 1:35 PM

$ABBV bought that dip. Looking for 237$ this summer.

0 · Reply

NRG8 May. 1 at 10:43 AM

$JNJ $ABBV $BAC $PG $CVX ..

0 · Reply

AirForce1000 May. 1 at 8:49 AM

$ABBV https://www.knicksnewyork.com LFG

0 · Reply

Maxwell_Osgood May. 1 at 12:33 AM

$ABBV

0 · Reply

VeltrixCapitalOfficial Apr. 30 at 11:39 PM

I AM THE BEST TRADER ON THIS SPACE🏆 $FDX 1,750%✅ $ABBV 1560% ✅ $AMZN 1,520% ✅ $AAPL 1,300%✅ $IBM 1,250%✅ $AAPL 1,200% ✅ OTHER TRADES POSTED ON TELEGRAM LINK IN BIO

1 · Reply

55X_ROI_Q1_2026 Apr. 30 at 10:11 PM

$SLS $ABBV $BMY $RRHBY Own Aza VEN - they Know PRECISELY how these drugs perform in AML Remission. - They've conducted many trials, including the VIALE-M and T P3's that Recently Failed. - if AzaVEN achieved the Durable OS we are seeing Now in the REGLA trial, VIALE-M Would NOT have been Terminated. MOST IMPORTANTLY - SLS Market Value Would NOT Have Increased 1,000% Since the IDMC Unblinded Actual MOS and IR Interim Data from the Ongoing P3 - They Know Precisely that its GPS

1 · Reply

Donib11 Apr. 30 at 8:02 PM

$ABBV not as strong of a close as I wanted, but still a nice Green Day! Let’s see 215+ tmrw 🥂

0 · Reply

AbbVie's Earnings Beat Wall Street's Estimates. Investors Are Still Worried

May 1, 2026, 10:03 AM EDT - 8 hours ago

Big Pharma M&A set for mega year as patent expiries drive deal urgency

BMY GILD GSK LLY

Apr 30, 2026, 3:00 PM EDT - 1 day ago

AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec

Apr 30, 2026, 9:00 AM EDT - 1 day ago

Allergan Aesthetics Launches Philanthropic Effort in Recognition of Skin Cancer Awareness Month

Apr 29, 2026, 2:49 PM EDT - 2 days ago

AbbVie Thanks 'Excellent Start To 2026' To Immunology And Neuroscience Strength

Apr 29, 2026, 9:00 AM EDT - 2 days ago

AbbVie Earnings Call Transcript: Q1 2026

Apr 29, 2026, 8:32 AM EDT - 2 days ago

AbbVie Raises FY Guidance on Immunology, Neuroscience Growth

Apr 29, 2026, 7:50 AM EDT - 2 days ago

AbbVie tops quarterly expectations as newer immunology drugs offset Humira decline

Apr 29, 2026, 7:47 AM EDT - 2 days ago

AbbVie Reports First-Quarter 2026 Financial Results

Apr 28, 2026, 8:00 AM EDT - 3 days ago

AbbVie Submits Application to FDA for Upadacitinib (RINVOQ®) for Adults and Adolescents with Severe Alopecia Areata

Apr 28, 2026, 7:00 AM EDT - 3 days ago

EvolveImmune Therapeutics Announces Achievement of Preclinical Milestone in Collaboration with AbbVie

Apr 27, 2026, 8:05 AM EDT - 4 days ago

AbbVie Submits Regulatory Application to FDA for SKYRIZI® (risankizumab-rzaa) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease

Apr 23, 2026, 4:19 PM EDT - 8 days ago

US FDA declines to approve AbbVie's wrinkle treatment

Apr 23, 2026, 4:05 PM EDT - 8 days ago

AbbVie Provides Update on TrenibotulinumtoxinE (TrenibotE) Biologics License Application in the U.S.

Apr 22, 2026, 12:59 PM EDT - 9 days ago

AbbVie to build $1.4 billion manufacturing campus in North Carolina

Apr 22, 2026, 12:02 PM EDT - 9 days ago

AbbVie Selects North Carolina for New $1.4 Billion Manufacturing Campus

Apr 20, 2026, 2:30 AM EDT - 11 days ago

Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases

Apr 15, 2026, 8:16 AM EDT - 16 days ago

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields

MDT

Apr 14, 2026, 8:50 AM EDT - 17 days ago

Erin Lichy Gets Real About Her Natrelle® Breast Augmentation

Apr 13, 2026, 2:24 AM EDT - 18 days ago

Haisco Enters into Exclusive License Agreement with AbbVie to Develop Novel Medicines for Pain

Apr 12, 2026, 7:15 AM EDT - 19 days ago

AbbVie Showcases Late‑Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx (ELAHERE®) in Platinum‑Sensitive Ovarian Cancer (PSOC) at SGO 2026

Apr 8, 2026, 1:38 PM EDT - 23 days ago

AbbVie files lawsuit to address 'outdated' drug discount eligibility program

Apr 8, 2026, 8:00 AM EDT - 23 days ago

BOTOX® Cosmetic (onabotulinumtoxinA) Empowers Women Entrepreneurs Through "The Confidence Collective" for Fourth Year

Apr 7, 2026, 9:53 AM EDT - 24 days ago

The price Americans pay for medicine has gotten horribly out of control. Here's how to fix it.

Apr 7, 2026, 9:00 AM EDT - 24 days ago

Allergan Aesthetics Third State-of-the-Art AMI Center Opens in Austin

Apr 3, 2026, 11:08 AM EDT - 4 weeks ago

Swiss industry body says US tariffs on pharmaceuticals will harm patients

AMGN AZN BMY MRK NVO

Apr 2, 2026, 5:34 PM EDT - 4 weeks ago

Trump Administration Unveils Up to 100% Tariff on Branded Drugs

AZN NVO AMGN BMY MRK

Apr 2, 2026, 5:33 PM EDT - 4 weeks ago

Trump threatens 100% tariff on US drug makers that don't strike deals to lower prices

AMGN AZN BMY MRK NVO

Apr 2, 2026, 3:29 PM EDT - 4 weeks ago

Drugmakers face 100% tariff unless they cut prices or produce drugs in US

AZN NVO AMGN BMY MRK

Apr 2, 2026, 2:59 PM EDT - 4 weeks ago

Global pharma companies that have publicly announced Trump drug pricing agreements

AMGN AZN BMY MRK

Mar 31, 2026, 8:05 AM EDT - 4 weeks ago

Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting®

Mar 31, 2026, 8:00 AM EDT - 4 weeks ago

AbbVie to Host First-Quarter 2026 Earnings Conference Call

Mar 27, 2026, 10:00 AM EDT - 5 weeks ago

AbbVie to Highlight New Clinical and Real-World Evidence Advancing Standards of Care in Immune-Mediated Skin Diseases at the 2026 AAD Annual Meeting

Mar 24, 2026, 8:00 AM EDT - 5 weeks ago

AbbVie Named Official Pharmaceutical Partner of Major League Baseball

Mar 20, 2026, 12:11 PM EDT - 6 weeks ago

US FDA flags seizure risk with certain Parkinson's drugs, seeks label warnings

AMRX NVS OGN

Mar 19, 2026, 9:26 AM EDT - 6 weeks ago

Buy Or Fear AbbVie Stock At $210?

Mar 19, 2026, 3:00 AM EDT - 6 weeks ago

Allergan Aesthetics Reveals Evolution in Approach to Modern Aesthetic Treatments with Comprehensive Global Survey and New Educational Solutions

Mar 18, 2026, 2:23 PM EDT - 6 weeks ago

TrumpRx lists many medicines at prices higher than paid in UK

AMGN AZN BMY GILD GSK JNJ LLY

Mar 17, 2026, 2:32 PM EDT - 6 weeks ago

Big drugmakers must face US overcharge claims on medications for low-income patients

AZN NVS SNY

Mar 13, 2026, 9:00 AM EDT - 7 weeks ago

New York Plastic Surgical Group and Deep Blue Med Spa Named #1 in New York by Allergan Aesthetics for the Second Year in a Row

Mar 10, 2026, 11:20 AM EDT - 7 weeks ago

AbbVie Transcript: Leerink Global Healthcare Conference 2026

Mar 9, 2026, 8:00 AM EDT - 7 weeks ago

AbbVie Announces Positive Topline Results from a Phase 1 Multiple Ascending Dose Study of ABBV-295, a Long-Acting Amylin Analog, in Adults

Mar 3, 2026, 11:10 AM EST - 2 months ago

AbbVie Transcript: TD Cowen 46th Annual Health Care Conference

Mar 3, 2026, 8:00 AM EST - 2 months ago

AbbVie to Present at the Leerink Partners Global Healthcare Conference

Mar 2, 2026, 8:30 AM EST - 2 months ago

AbbVie Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI® (Risankizumab) Subcutaneous Induction in Patients with Crohn's Disease

Feb 24, 2026, 8:00 AM EST - 2 months ago

AbbVie to Present at the TD Cowen 46th Annual Health Care Conference

Feb 23, 2026, 12:03 PM EST - 2 months ago

AbbVie to invest $380 million to expand US manufacturing in Illinois

Feb 23, 2026, 11:00 AM EST - 2 months ago

AbbVie to Invest $380 Million in North Chicago to Further Expand Active Pharmaceutical Ingredient Manufacturing in the United States

Feb 20, 2026, 2:00 AM EST - 2 months ago

U.S. Food and Drug Administration (FDA) Approves Combination Treatment of VENCLEXTA® (venetoclax) and Acalabrutinib for Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL)

Feb 19, 2026, 9:37 AM EST - 2 months ago

AbbVie Declares Quarterly Dividend

Feb 13, 2026, 10:00 AM EST - 2 months ago

AbbVie Transcript: Piper Sandler Virtual Novel Targets in Immunology Symposium

Feb 11, 2026, 6:49 PM EST - 2 months ago

AbbVie sues US health agency over Botox price controls

Feb 11, 2026, 5:13 PM EST - 2 months ago

Abbvie sues US health agency over Botox

Feb 4, 2026, 12:38 PM EST - 3 months ago

AbbVie's Inflammation Drug Humira Slows, But Skyrizi, Rinvoq Drive Revenue Growth

Feb 4, 2026, 9:00 AM EST - 3 months ago

AbbVie Earnings Call Transcript: Q4 2025

Jan 14, 2026, 11:15 AM EST - 3 months ago

AbbVie Transcript: 44th Annual J.P. Morgan Healthcare Conference

Dec 3, 2025, 8:30 AM EST - 5 months ago

AbbVie Transcript: Piper Sandler 37th Annual Healthcare Conference

Nov 14, 2025, 11:55 AM EST - 6 months ago

AbbVie Transcript: 7th Annual Healthcare Symposium

Oct 31, 2025, 9:00 AM EDT - 6 months ago

AbbVie Earnings Call Transcript: Q3 2025

Sep 9, 2025, 10:00 AM EDT - 8 months ago

AbbVie Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Jul 31, 2025, 9:00 AM EDT - 9 months ago

AbbVie Earnings Call Transcript: Q2 2025

Jun 10, 2025, 11:20 AM EDT - 11 months ago

AbbVie Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

May 14, 2025, 1:00 PM EDT - 1 year ago

AbbVie Transcript: BofA Securities 2025 Healthcare Conference

May 9, 2025, 10:00 AM EDT - 1 year ago

AbbVie Transcript: AGM 2025

Apr 25, 2025, 9:00 AM EDT - 1 year ago

AbbVie Earnings Call Transcript: Q1 2025

Mar 11, 2025, 8:40 AM EDT - 1 year ago

AbbVie Transcript: Leerink’s Global Healthcare Conference 2025

Mar 5, 2025, 9:10 AM EST - 1 year ago

AbbVie Transcript: TD Cowen 45th Annual Healthcare Conference

Jan 31, 2025, 9:00 AM EST - 1 year ago

AbbVie Earnings Call Transcript: Q4 2024

Jan 15, 2025, 11:15 AM EST - 1 year ago

AbbVie Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Dec 3, 2024, 10:15 AM EST - 1 year ago

AbbVie Transcript: Citi's 2024 Global Healthcare Conference

Oct 30, 2024, 9:00 AM EDT - 1 year ago

AbbVie Earnings Call Transcript: Q3 2024

Jul 25, 2024, 9:00 AM EDT - 1 year ago

AbbVie Earnings Call Transcript: Q2 2024

Jun 12, 2024, 10:00 AM EDT - 2 years ago

AbbVie Transcript: Goldman Sachs 45th Annual Global Healthcare Conference

May 15, 2024, 1:40 PM EDT - 2 years ago

AbbVie Transcript: BofA Securities 2024 Health Care Conference

May 3, 2024, 10:00 AM EDT - 2 years ago

AbbVie Transcript: ASM 2024

Apr 26, 2024, 9:00 AM EDT - 2 years ago

AbbVie Earnings Call Transcript: Q1 2024

Mar 14, 2024, 9:00 AM EDT - 2 years ago

AbbVie Transcript: Barclays 26th Annual Global Healthcare Conference 2024

Mar 5, 2024, 9:10 AM EST - 2 years ago

AbbVie Transcript: TD Cowen 44th Annual Health Care Conference 2024

Feb 2, 2024, 9:00 AM EST - 2 years ago

AbbVie Earnings Call Transcript: Q4 2023

Jan 10, 2024, 11:15 AM EST - 2 years ago

AbbVie Transcript: J.P. Morgan 42nd Annual Healthcare Conference 2024

Dec 7, 2023, 9:00 AM EST - 2 years ago

AbbVie Transcript: M&A Announcement

Nov 30, 2023, 9:00 AM EST - 2 years ago

AbbVie Transcript: M&A Announcement

Oct 27, 2023, 9:00 AM EDT - 2 years ago

AbbVie Earnings Call Transcript: Q3 2023

Sep 13, 2023, 10:50 AM EDT - 2 years ago

AbbVie Transcript: Morgan Stanley 21st Annual Global Healthcare Conference 2023

Jul 27, 2023, 9:00 AM EDT - 3 years ago

AbbVie Earnings Call Transcript: Q2 2023

May 9, 2023, 11:00 AM EDT - 3 years ago

AbbVie Transcript: Bank of America Global Healthcare Conference

Apr 27, 2023, 9:00 AM EDT - 3 years ago

AbbVie Earnings Call Transcript: Q1 2023

Mar 15, 2023, 1:35 PM EDT - 3 years ago

AbbVie Transcript: Barclays Global Healthcare Conference

Mar 7, 2023, 9:10 AM EST - 3 years ago

AbbVie Transcript: Cowen Health Care Conference

Feb 9, 2023, 9:00 AM EST - 3 years ago

AbbVie Earnings Call Transcript: Q4 2022

Jan 10, 2023, 6:00 PM EST - 3 years ago

AbbVie Transcript: JPMorgan Healthcare Conference

Oct 28, 2022, 9:00 AM EDT - 3 years ago

AbbVie Earnings Call Transcript: Q3 2022

Jul 29, 2022, 6:27 AM EDT - 4 years ago

AbbVie Earnings Call Transcript: Q2 2022

Apr 29, 2022, 12:59 PM EDT - 4 years ago

AbbVie Earnings Call Transcript: Q1 2022

Feb 2, 2022, 2:50 PM EST - 4 years ago

AbbVie Earnings Call Transcript: Q4 2021

Jan 11, 2022, 5:44 AM EST - 4 years ago

AbbVie Transcript: J.P. Morgan Healthcare Conference

Oct 28, 2021, 8:00 PM EDT - 4 years ago

AbbVie Earnings Call Transcript: Q3 2021

Jul 29, 2021, 8:20 PM EDT - 5 years ago

AbbVie Earnings Call Transcript: Q2 2021

May 7, 2021, 5:53 AM EDT - 5 years ago

AbbVie Transcript: ASM 2021

Apr 30, 2021, 8:42 AM EDT - 5 years ago

AbbVie Earnings Call Transcript: Q1 2021

Feb 3, 2021, 9:00 AM EST - 5 years ago

AbbVie Earnings Call Transcript: Q4 2020

Dec 14, 2020, 10:00 AM EST - 5 years ago

AbbVie Transcript: Strategy Update

Oct 30, 2020, 9:00 AM EDT - 5 years ago

AbbVie Earnings Call Transcript: Q3 2020

Jul 31, 2020, 9:00 AM EDT - 6 years ago

AbbVie Earnings Call Transcript: Q2 2020

May 8, 2020, 10:00 AM EDT - 6 years ago

AbbVie Transcript: ASM 2020

May 1, 2020, 9:00 AM EDT - 6 years ago

AbbVie Earnings Call Transcript: Q1 2020

Feb 7, 2020, 9:00 AM EST - 6 years ago

AbbVie Earnings Call Transcript: Q4 2019

Nov 1, 2019, 9:00 AM EDT - 7 years ago

AbbVie Earnings Call Transcript: Q3 2019

Jul 26, 2019, 9:00 AM EDT - 7 years ago

AbbVie Earnings Call Transcript: Q2 2019

Jun 25, 2019, 8:30 AM EDT - 7 years ago

AbbVie Transcript: M&A Announcement

Apr 25, 2019, 9:00 AM EDT - 7 years ago

AbbVie Earnings Call Transcript: Q1 2019

Jan 25, 2019, 9:00 AM EST - 7 years ago

AbbVie Earnings Call Transcript: Q4 2018

Nov 2, 2018, 9:00 AM EDT - 8 years ago

AbbVie Earnings Call Transcript: Q3 2018

Jul 27, 2018, 9:00 AM EDT - 8 years ago

AbbVie Earnings Call Transcript: Q2 2018

Apr 26, 2018, 9:00 AM EDT - 8 years ago

AbbVie Earnings Call Transcript: Q1 2018

Jan 26, 2018, 9:00 AM EST - 8 years ago

AbbVie Earnings Call Transcript: Q4 2017

Oct 27, 2017, 9:00 AM EDT - 9 years ago

AbbVie Earnings Call Transcript: Q3 2017

Jul 28, 2017, 9:00 AM EDT - 9 years ago

AbbVie Earnings Call Transcript: Q2 2017

Apr 27, 2017, 9:00 AM EDT - 9 years ago

AbbVie Earnings Call Transcript: Q1 2017

Jan 27, 2017, 9:00 AM EST - 10 years ago

AbbVie Earnings Call Transcript: Q4 2016

Oct 28, 2016, 9:00 AM EDT - 10 years ago

AbbVie Earnings Call Transcript: Q3 2016

Jul 29, 2016, 9:00 AM EDT - 10 years ago

AbbVie Earnings Call Transcript: Q2 2016

Jun 3, 2016, 10:00 AM EDT - 10 years ago

AbbVie Transcript: R&D Day 2016

Apr 28, 2016, 9:00 AM EDT - 10 years ago

AbbVie Earnings Call Transcript: Q1 2016

Jan 29, 2016, 9:00 AM EST - 11 years ago

AbbVie Earnings Call Transcript: Q4 2015

Oct 30, 2015, 10:00 AM EDT - 11 years ago

AbbVie Earnings Call Transcript: Q3 2015

Jul 24, 2015, 9:00 AM EDT - 11 years ago

AbbVie Earnings Call Transcript: Q2 2015

Apr 23, 2015, 9:00 AM EDT - 11 years ago

AbbVie Earnings Call Transcript: Q1 2015

Mar 5, 2015, 9:00 AM EST - 12 years ago

AbbVie Transcript: M&A Announcement

Jan 30, 2015, 9:00 AM EST - 12 years ago

AbbVie Earnings Call Transcript: Q4 2014

Oct 31, 2014, 9:00 AM EDT - 12 years ago

AbbVie Earnings Call Transcript: Q3 2014

Jul 25, 2014, 9:00 AM EDT - 12 years ago

AbbVie Earnings Call Transcript: Q2 2014

Apr 25, 2014, 9:00 AM EDT - 13 years ago

AbbVie Earnings Call Transcript: Q1 2014

Jan 31, 2014, 9:00 AM EST - 13 years ago

AbbVie Earnings Call Transcript: Q4 2013

Oct 25, 2013, 9:00 AM EDT - 13 years ago

AbbVie Earnings Call Transcript: Q3 2013

Jul 26, 2013, 9:00 AM EDT - 13 years ago

AbbVie Earnings Call Transcript: Q2 2013

Apr 26, 2013, 9:00 AM EDT - 14 years ago

AbbVie Earnings Call Transcript: Q1 2013

Jan 30, 2013, 9:00 AM EST - 14 years ago

AbbVie Earnings Call Transcript: Q4 2012

UsingAGodAlgorithm May. 1 at 10:08 PM

$SE (-75% from short entry) We are the best on ST as far as we have seen. Check our profile We also covered these names. $ABBV $PLTR $MU $MA

0 · Reply

SlightlyHippy May. 1 at 9:31 PM

$JNJ & $ABBV pick up the dips!!

0 · Reply

55X_ROI_Q1_2026 May. 1 at 6:34 PM

0 · Reply

Chartist0_0 May. 1 at 1:35 PM

$ABBV bought that dip. Looking for 237$ this summer.

0 · Reply

NRG8 May. 1 at 10:43 AM

$JNJ $ABBV $BAC $PG $CVX ..

0 · Reply

AirForce1000 May. 1 at 8:49 AM

$ABBV https://www.knicksnewyork.com LFG

0 · Reply

Maxwell_Osgood May. 1 at 12:33 AM

$ABBV

0 · Reply

VeltrixCapitalOfficial Apr. 30 at 11:39 PM

I AM THE BEST TRADER ON THIS SPACE🏆 $FDX 1,750%✅ $ABBV 1560% ✅ $AMZN 1,520% ✅ $AAPL 1,300%✅ $IBM 1,250%✅ $AAPL 1,200% ✅ OTHER TRADES POSTED ON TELEGRAM LINK IN BIO

1 · Reply

55X_ROI_Q1_2026 Apr. 30 at 10:11 PM

1 · Reply

Donib11 Apr. 30 at 8:02 PM

$ABBV not as strong of a close as I wanted, but still a nice Green Day! Let’s see 215+ tmrw 🥂

0 · Reply

55X_ROI_Q1_2026 Apr. 30 at 7:57 PM

$SLS +/- 60 Events for the Control Arm While we Await 80 Gps Phase 3 MOS is > 30 Months and Not Yet Reached. For the Short BUS Crew Aza+VEN, BAT / Best Available Treatment for REGAL P3 CONTROL ARM patients Recently FAILED 3 Large Phase 3 Trials - since August 2025, 3 P3 AZA VEN Trials Conducted by $ABBV Failed. - its Gps Immunotherapy doing what its always done, BAT - Failed... - VERONA Failed to show OS benefit - VIALE-T FAILED for aml transplant maintenance - VIALE-M FAILED for AML CR1 Remission Maintenance FAILED - 7 DIFFERENT DOSING COHORTS - all Oral, all combo's FAILED. BAT FAILED - its Gps causing the Near Miraculous survival.

0 · Reply

focafoca99 Apr. 30 at 7:50 PM

$ABBV honored RIME Therapeutics with its Quebec biotech innovators award in partnership with adMare BioInnovations. https://www.rapidticker.com/news/abbv-abbvie-et-admare-bioinnovations-nomment-5c77ab

0 · Reply

Donib11 Apr. 30 at 7:10 PM

$ABBV great start to power hour boys and gals! Keep it going, SHOW ME 215

0 · Reply

Donib11 Apr. 30 at 6:35 PM

$ABBV pls explode during power hour 🙏

0 · Reply

DHouston7 Apr. 30 at 6:32 PM

$ABBV love this juggernaut. Goes down, buy. Goes up, buy. Goes sideways, buy. Been in it since 1-1-13 😎

0 · Reply

ksoption Apr. 30 at 6:19 PM

$ABBV $TSLA

0 · Reply

NRG8 Apr. 30 at 5:19 PM

$JNJ $ABBV $BAC $PG $CVX . ..

0 · Reply

Donib11 Apr. 30 at 5:08 PM

$ABBV GIVE ME 215 BABYYYYY

0 · Reply

OptiMusktic Apr. 30 at 4:47 PM

$ABBV

0 · Reply

Scanlz Apr. 30 at 4:46 PM

$ABBV Estimated price prediction by 2030 ranges from $275-$320 so even owning below 100 shares will give you a good gain.

0 · Reply

Donib11 Apr. 30 at 4:40 PM

$ABBV @jbops3 how are you doing my child? 😂

0 · Reply

CapitalMonk Apr. 30 at 4:15 PM

$ABBV Price: $212.40 (+4.18%) Trend: Bearish Market Bias (7D): Bearish Bias 📉 Expected Range: ±0.73% RSI: 58.5 | Momentum: Moderate Volume: -40.7% vs avg Volatility: 1.83% Support: $190.75 | Resistance: $214.87 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25

0 · Reply

Market Cap	360.51B
Revenue (ttm)	61.16B
Net Income (ttm)	4.23B
EPS (ttm)	N/A
PE Ratio	19.77
Forward PE	13.92
Profit Margin	6.91%
Debt to Equity Ratio	-20.91

Volume	6,341,369
Avg Vol	7,028,170
Day's Range	N/A - N/A
Shares Out	1.77B
Stochastic %K	85%
Beta	0.38
Analysts	Strong Sell
Price Target	$249.93